Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review, Lancet Glob. Health, vol.5, pp.1192-1207, 2017. ,
, HIV/STI Integrated Biological and Behavioral Surveillance (IBBS) in, 2014.
, Country Profile: Vietnam, 2017.
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review, AIDS Behav, vol.17, pp.2878-2892, 2013. ,
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis, Int. J. Epidemiol, vol.43, pp.235-248, 2014. ,
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs, Am. J. Public Health, vol.85, pp.1577-1584, 1995. ,
Methadone maintenance treatment (MMT): a review of historical and clinical issues, Mt. Sinai J. Med. N. Y, vol.67, pp.347-364, 2000. ,
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and metaanalysis, BMJ, vol.345, p.5945, 2012. ,
HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks, AIDS Lond. Engl, vol.30, pp.815-826, 2016. ,
Prevalence and risk factors for hepatitis C infection in rural north Vietnam, Hepatol. Int, vol.1, pp.387-393, 2007. ,
Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study, AIDS Care, vol.21, pp.7-16, 2009. ,
Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection, J. Urban Health Bull. N. Y. Acad. Med, vol.87, pp.278-291, 2010. ,
Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam, J. Int. Assoc. Physicians AIDS Care Chic. Ill2002, vol.11, pp.311-320, 2012. ,
Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam, Eur. J. Gastroenterol. Hepatol, vol.27, pp.550-556, 2015. ,
Sexual practices, partner concurrency and high rates of sexually transmissible infections among male sex workers in three cities in Vietnam, Sex. Health, vol.12, pp.39-47, 2015. ,
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis, Addict. Abingdon Engl, vol.113, pp.545-563, 2018. ,
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, PloS One, vol.9, p.97726, 1996. ,
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions, AIDS Care, vol.28, pp.1312-1315, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01868886
Mortality and HIV transmission among male Vietnamese injection drug users, Addict. Abingdon Engl, vol.106, pp.583-589, 2011. ,
Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis, BMC Public Health, vol.15, p.32, 2015. ,
Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) -Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus, PloS One, vol.10, p.118304, 2015. ,
Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam, J. Med. Virol, vol.82, pp.1355-1363, 2010. ,
Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants, PloS One, vol.7, p.41266, 2012. ,
Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from, PLoS ONE, vol.12, 2007. ,
HCV epidemiology in high-risk groups and the risk of reinfection, J. Hepatol, vol.65, pp.33-45, 2016. ,
An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection, J. Infect. Dis, vol.207, issue.1, pp.1-6, 2013. ,
Interventions to reduce HIV transmission related to injecting drug use in prison, Lancet Infect. Dis, vol.9, pp.57-66, 2009. ,
The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations, Gastroenterol. Hepatol, vol.12, pp.1-11, 2016. ,
Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study, Lancet Gastroenterol. Hepatol, vol.2, pp.200-210, 2017. ,
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort, J. Hepatol, vol.69, pp.1007-1014, 2018. ,
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users, J. Infect. Dis, vol.202, pp.984-990, 2010. ,
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?, Addict. Abingdon Engl, 2018. ,
Elimination of HCV as a public health concern among people who inject drugs by 2030 -What will it take to get there?, J. Int. AIDS Soc, vol.20, p.22146, 2017. ,